{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Joanna Kirkpatrick"}, {"accession": "MS:1000589", "name": "contact email", "value": "joanna.kirkpatrick@leibniz-fli.de"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "The Francis Crick Institute"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Zhao-Qi Wang"}, {"accession": "MS:1000589", "name": "contact email", "value": "zhao-qi.wang@leibniz-fli.de"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Leibniz Institute on Aging Fritz Lipmann Institute (FLI) Beutenbergstr. 11 07745 Jena, Germany"}]}], "datasetFiles": [{"accession": "MS:1002851", "name": "Other type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/checksum.txt"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DDA_AUY922VE821_15.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DDA_AUY922_5.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DDA_VE821_11.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DDA_ctrl_1.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DIA_AUY922VE821_13.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DIA_AUY922VE821_14.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DIA_AUY922VE821_15.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DIA_AUY922_5.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DIA_AUY922_6.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DIA_AUY922_7.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DIA_VE821_10.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DIA_VE821_11.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DIA_VE821_9.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DIA_ctrl_1.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DIA_ctrl_2.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190802_EKS_CM_DIA_ctrl_3.raw"}, {"accession": "MS:1002845", "name": "Associated file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190806_JMK_CM_Human_ATR_DpD_QEHFX.kit"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190807_JMK_CM_Human_ATR_DpD_lib_all_rep_4s_removed_paired.sne"}, {"accession": "MS:1002845", "name": "Associated file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/190807_JMK_CM_Human_ATR_DpD_lib_candidates_all_rep_4s_removed_paired.xls"}, {"accession": "MS:1002845", "name": "Associated file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/contaminants_20120713.fasta"}, {"accession": "MS:1002845", "name": "Associated file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562/sp_human_160126.fasta"}], "description": "Ewing's sarcoma (ES) is the second most frequent bone cancer during childhood and adolescence originating from a translocation between the EWSR1 and the FLI1 gene, which inactivates BRCA-mediated DNA damage response. Both ATR and HSP90 inhibitors are promising new candidates in the field of ES treatment. We show that the HSP90 inhibitor AUY922 alone induced DNA damages, apoptosis and ER stress, while reducing the abundance of DNA repair proteins. The combinations of the ATR inhibitor VE821 and AUY922 (AUY-VE) led to strong apoptosis induction in ES cell lines, originating from a common set of molecular targets and independent of their p53 status, yet based on different molecular mechanisms. P53 wild-type ES cells activated pro-apoptotic gene transcription and underwent mitochondria-mediated apoptosis. P53 null ES cells, however, accumulated higher level of DNA damage, ER stress and autophagy, finally leading to apoptosis. Moreover, AUY-VE treatment compromised ES cell vitality due to impaired PI3K/AKT/mTOR signaling. Unexpectedly, the combinations of AUY922 with the ATM inhibitor, KU55933 failed to kill ES cells and showed protective effects compared to AUY-VE. In summary, we provide mechanistic insights into the effective ES cell killing by ATR and HSP90 inhibitor combinations, which also offers a targetable approach for BRCA-deficient tumors, irrespective of their p53 status and may give rise to new therapeutic strategies.", "fullDatasetLinks": [{"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD021562"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD021562"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD021562"}], "instruments": [{"accession": "MS:1002877", "name": "Q Exactive HF-X"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Ewing's sarcoma"}], "modifications": [{"accession": "MOD:00394", "name": "acetylated residue"}, {"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "33743824"}, {"accession": "MS:1002866", "name": "Reference", "value": "Marx C, Schaarschmidt MU, Kirkpatrick J, Marx-Bl\u00fcmel L, Halilovic M, Westermann M, Hoelzer D, Meyer FB, Geng Y, Buder K, Schadwinkel HM, Siniuk K, Becker S, Thierbach R, Beck JF, Sonnemann J, Wang ZQ. Cooperative treatment effectiveness of ATR and HSP90 inhibition in Ewing's sarcoma cells. Cell Biosci. 2021 11(1):57"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Cooperative treatment effectiveness of VE821 and AUY922 in Ewing\u2019s sarcoma cells"}